Injectable Drug Delivery: May 11-12, 2022

As part of Europe’s leading Injectable conference series, the Injectable Drug Delivery conference will assess innovations in drug product formulation and biologics, new technologies in device design, and the use of long-release injectable compounds.

Dates: May 11-12, 2022

Location: London, UK

Description: There is a rising demand for vaccines, insulin, and many modern medicines used to treat cancer and other chronic diseases. As biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to drive the injectable drug delivery and prefilled syringe market in the coming years. The injectable drug delivery market is expected to rise at a compound annual growth rate of 12.9% reaching £915 billion by 2027.

This year’s event will highlight innovations within the industry with regard to injectable device design and the formulation challenges of long-lasting, highly viscous and high volume drug delivery. There will be an additional focus on the impact that covid has had on advances within this industry over the past year. The conference will also highlight the significance of sustainability within the injectable drug delivery industry, whilst providing regulatory insight on the changes that have occurred.